Blood test may detect lung cancer in early stages - Reuters
CHICAGO (Reuters) - A simple blood test may be able to detect lung cancer in its early stages, which would represent a promising strategy to improve survival rates, researchers said on Sunday. The two-year survival rate is only about 15 percent
Source: www.reuters.com

Infant fights rare cancer - North Bay Nugget
It’s unusual that an eight-month-old North Bay boy would develop a certain type of cancer that affects the blood and bone marrow. It’s even more unusual the way it showed up on his body. There were no symptoms, nothing to suggest there was anything
Source: www.nugget.ca

Medivation Announces Presentation of Positive MDV3100 Clinical Data in - Forbes
SAN FRANCISCO and CHICAGO, June 2 /PRNewswire-FirstCall/ — Medivation, Inc. (Nasdaq: MDVN) today announced that data from an ongoing Phase 1-2 clinical trial of the Company’s novel androgen receptor antagonist, MDV3100, showed encouraging anti-tumor
Source: www.forbes.com

Wall Street: Genentech to lead lung cancer market - CNBC
NEW YORK - Genentech Inc.’s drug Avastin will likely remain dominant in the lung cancer market over rival ImClone Systems Inc.’s Erbitux, several analysts said Monday following the release of clinical data at the American Society of Clinical Oncology
Source: www.cnbc.com

Celgene’s Revlimid shows results for blood cancer - MSN MoneyCentral
CHICAGO (AP) - Celgene Corp. said late Sunday that a mid-stage study showed that 29 percent of patients with a certain type of blood cancer responded to its drug Revlimid. The data was presented at the American Society of Clinical Oncology meeting in
Source: moneycentral.msn.com

ASCO AT A GLANCE: Genetic Research A Focus Of Cancer Meeting - CNN Money
THE EVENT: Thousands of cancer specialists are in Chicago this week attending the 44th annual meeting of the American Society of Clinical Oncology, where pharmaceutical and biotech companies are providing updates on 4,200 studies. The five-day ASCO
Source: money.cnn.com